Cargando…
Isovalerylspiramycin I suppresses non-small cell lung carcinoma growth through ROS-mediated inhibition of PI3K/AKT signaling pathway
Novel drugs are required for non-small cell lung cancer (NSCLC) treatment urgently. Repurposing old drugs as new treatments is a practicable approach with time and cost savings. Some studies have shown that carrimycin, a Chinese Food and Drug Administration (CFDA)-approved macrolide antibiotic, poss...
Autores principales: | Liu, Zeyu, Huang, Moli, Hong, Yue, Wang, Shaoyang, Xu, Yongle, Zhong, Cheng, Zhang, Jingyuan, Zhuang, Zhengping, Shan, Shan, Ren, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254468/ https://www.ncbi.nlm.nih.gov/pubmed/35813464 http://dx.doi.org/10.7150/ijbs.69989 |
Ejemplares similares
-
Targeting selenoprotein H in the nucleolus suppresses tumors and metastases by Isovalerylspiramycin I
por: Cui, Jing, et al.
Publicado: (2022) -
Anti-Tumor Effects of Carrimycin and Monomeric Isovalerylspiramycin I on Hepatocellular Carcinoma in Vitro and in Vivo
por: Jin, Yong, et al.
Publicado: (2021) -
Bruceine a exerts antitumor effect against colon cancer by accumulating ROS and suppressing PI3K/Akt pathway
por: Zhang, Chaozheng, et al.
Publicado: (2023) -
Hypoxia-induced Nur77 activates PI3K/Akt signaling via suppression of Dicer/let-7i-5p to induce epithelial-to-mesenchymal transition
por: Shi, Zeyu, et al.
Publicado: (2021) -
Chlorpyrifos induces male infertility in pigs through ROS and PI3K-AKT pathway
por: Zhang, Xuelian, et al.
Publicado: (2023)